Nuvation Bio Q1 EPS $(0.16), Inline, Sales $3.08M Beat $416.67K Estimate

Benzinga · 05/07 20:33
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate. This is a 128.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $3.08 million which beat the analyst consensus estimate of $416.67 thousand by 640.16 percent.